These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 27470356

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Progression of squamous cell carcinoma is regulated by miR-139-5p/CXCR4.
    Jiang Q, Cao Y, Qiu Y, Li C, Liu L, Xu G.
    Front Biosci (Landmark Ed); 2020 Jun 01; 25(9):1732-1745. PubMed ID: 32472755
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O, Hasegawa S, Nagai H, Uchida F, Yamatoji M, Kanno NI, Yamagata K, Sakai S, Yanagawa T, Bukawa H.
    J Oral Pathol Med; 2016 Apr 01; 45(4):248-55. PubMed ID: 26307116
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
    Li N, Nan CC, Zhong XY, Weng JQ, Fan HD, Sun HP, Tang S, Shi L, Huang SX.
    Cell Physiol Biochem; 2018 Apr 01; 49(4):1329-1341. PubMed ID: 30205384
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
    Li L, Ma HQ.
    Mol Med Rep; 2015 Aug 01; 12(2):3156-62. PubMed ID: 25955794
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP‑2 expression.
    Nagai H, Hasegawa S, Uchida F, Terabe T, Ishibashi Kanno N, Kato K, Yamagata K, Sakai S, Kawashiri S, Sato H, Yanagawa T, Bukawa H.
    Int J Oncol; 2018 Mar 01; 52(3):841-850. PubMed ID: 29393341
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
    Lin SC, Kao SY, Chang JC, Liu YC, Yu EH, Tseng SH, Liu CJ, Chang KW.
    Oncotarget; 2016 Sep 20; 7(38):61355-61365. PubMed ID: 27542258
    [Abstract] [Full Text] [Related]

  • 19. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
    Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, Kuo MY, Jeng YM, Kuo ML, Chang CC.
    Oncogene; 2012 May 10; 31(19):2401-11. PubMed ID: 21927029
    [Abstract] [Full Text] [Related]

  • 20. MiR-32-5p promoted epithelial-to-mesenchymal transition of oral squamous cell carcinoma cells via regulating the KLF2/CXCR4 pathway.
    Qin SY, Li B, Chen M, Qin MQ, Liu JM, Lv QL.
    Kaohsiung J Med Sci; 2022 Feb 10; 38(2):120-128. PubMed ID: 34741382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.